Search Results - "Elmegaard, M"

Kidney status and events preceding death in heart failure: A real world data study on 18,456 patients with heart failure by Zahir, D, Elmegaard, M E, Garred, C G, Jhund, P, Petrie, M, Mcmurray, J, Kober, L K, Schou, M S

“…Abstract Background Despite advancements in heart failure (HF) management, kidney dysfunction remains a significant clinical challenge, and is associated with…”
Get full text

Patient characteristics and mortality trends among octogenarians with heart failure over two decades - a Danish nationwide study by Garred, C A H, Elmegaard, M, Christensen, D M, Zahir, D, Malmborg, M, Fosboel, E, Pardeep, J, Mcmurray, J, Petrie, M, Andersson, C, Koeber, L, Schou, M

“…Abstract Background Mortality rates among octogenarians with heart failure (HF) have changed little despite significant advancements in care over recent…”
Get full text

Effects of body mass index on worsening of heart failure and all-cause death in patients with heart failure and reduced left ventricular ejection fraction: a 10-year follow-up study by Malmborg, M, Fuchs Andersen, A, Elmegaard, M, Garred, C, Zahir, D, Butt, J, Christensen, D, Nouhravesh, N, Videbaek, L, Kober, L, Gustafsson, F, Schou, M

“…Abstract Background/Introduction Obesity in patients with heart failure (HF) with reduced ejection fraction (HFrEF) is common, and with the emergence of…”
Get full text

Dapagliflozin versus empagliflozin and major adverse cardiovascular events in type 2 diabetes: a nationwide cohort study by Alhakak, A, Kober, L, Petrie, M C, Jhund, P S, Dridi, N P, Karacan, M N, Schou, M, Elmegaard, M, Rossing, P, Fosbol, E, Butt, J H

“…Abstract Background Large randomized clinical trials have shown that sodium-glucose co-transporter-2 (SGLT2) inhibitors reduce the risk of adverse kidney and…”
Get full text

Determinants of changes in peak oxygen consumption in patients with new onset heart failure by Jensen, M, Thunestvedt, M T, Lamberts, M L, Schou, M S, Nielsen, S N, Elmegaard, M E, Nouhravesh, N N, Holt, A H, Shurenberg, C S, Wolsk, E W

“…Abstract Background Patients with heart failure (HF) with reduced ejection fraction (HFrEF) have a high risk of mortality. Cardio-Pulmonary Exercise Test…”
Get full text

Implementation of sodium-glucose co-transporter 2 inhibitors in patients with heart failure through a new digital strategy (EMAIL-HF): a randomised clinical trial study design by Elmegaard, M, Koeber, L, Mouridsen, M R, Lauridsen, T K, Dridi, N P, Wolsk, E, Thune, J J, Ersboell, M K, Petersen, M, Lamberts, M K, Stride, N O, Barasa, A, Bonfils, P, Tuxen, C D, Schou, M

“…Abstract Introduction Delayed implementation of new medical discoveries remains a global healthcare challenge and is mainly due to the complexity of…”
Get full text

Assessing one-year risk of heart failure following first time myocardial infarction and subsequent five-year mortality risk: a nationwide study of 34,401 patients by Zahir, D, Christensen, D M, Elmegaard, M E, Nouhravesh, N N, Garred, C G, Fosboel, E F, Butler, J B, Hernandez, A H, Petrie, M A R K, Kober, L K, Schou, M S

“…Abstract Introduction A comprehensive understanding of the post-myocardial infarction (MI) trajectory leading to heart failure (HF) and its profound impact on…”
Get full text

Temporal trends in initiation of oral anticoagulants and stroke-free survival among elderly and very elderly patients with new onset atrial fibrillation - a 20-year perspective by Larsen, S, Elmegaard, M, Binding, C, Hartwell Garred, C, Sindet-Pedersen, C, Loldrup Fosboel, E, Holt, A, Nouhravesh, N, Lamberts, M, Christensen, D, Koeber, L, Bjerring Olesen, J, Schou, M

“…Abstract Background Oral anticoagulants (OACs) significantly reduce the risk of ischemic stroke in patients with atrial fibrillation (AF). However, evidence…”
Get full text

Temporal trends in treatment patterns, morbidity, and mortality in patients with new-onset heart failure compared to heart failure survivors: a nationwide 23-year perspective by Boysen, E, Koeber, L, Kjoebek Lamberts, M, Godsk Joergensen, P, Ditlev Tuxen, C, Wolsk, E, Ersboell, M, Barasa, A, Rauhe Mouridsen, M, Kiilerich Lauridsen, T, Dridi, N, Petersen, M, Thune, J J, Schou, M, Elmegaard Malik, M

“…Abstract Background New therapy options have improved the prognosis of heart failure (HF) over recent decades. However, temporal trends in the prognosis and…”
Get full text

Impact of various iron deficiency definitions on mortality risk in chronic heart failure across the spectrum of left ventricular ejection fraction spectrum by Mohamed, A, Daniel Moelager Christensen, D M C, Milan Mohammad, M M, Christian Torp-Pedersen, C T P, Lars Koeber, L K, Emil Loldrup Fosboel, E L F, Tor Biering-Soerensen, T B S, Morten Lock, M L, Mariam Elmegaard Malik, M E M, Nina Nouhravesh, N N, Charlotte Anderrson, C A, Morten Schou, M S, Gunnar Gislason, G G

“…Abstract Introduction Iron deficiency (ID) is prevalent in chronic heart failure (HF) but lacks a consensus definition. Purpose This study evaluates the…”
Get full text

Temporal trends in mortality and hospitalisation risk in patients with heart failure according to frailty status by Abassi, N, Nina Nouhravesh, N N, Mariam Elmegaard Malik, M E M, Marte Austreim, M A, Deewa Zahir Anjum, D Z A, Caroline Hartwell Garred, C H G, Jawad Haider Butt, J H B, Camilla Fuchs Andersen, C F A, Jarl Emmanuel Strange, J E S, Caroline Sindet-Pedersen, C S P, Daniel Molager Christiansen, D M C, Emil Fosbol, E F, Charlotte Andersson, C A, Lars Kober, L K, Morten Schou, M S

“…Abstract Background Heart failure (HF) and frailty often coexist, and patients with both conditions have a higher risk of mortality and hospitalisation…”
Get full text

3268Impact of heart failure on prognosis compared to other complications in patients with diabetes mellitus type 2 by Zareini, B, Blanche, P B, D'Souza Diederichsen, M D D, Elmegaard Malik, M E M, Lund Kristsensen, S L K, Selmer, C S, Koeber, L K, Gislason, G G, Torp-Pedersen, C T P, Schou, M S, Lamberts, M L

“…Abstract Background Recent studies have highlighted a high incidence of heart failure (HF) in type 2 diabetes mellitus (T2D), but it remains unclear how the…”
Get full text